UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

Current Report

Pursuant to Section 13 or 15(d) of The

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 24, 2010

 

 

UNITEDHEALTH GROUP INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

 

Minnesota		0-10864		41-1321939
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

 

UnitedHealth Group Center, 9900 Bren Road East, Minnetonka, Minnesota		55343
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (952) 936-1300

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

Item 5.07.

Submission of Matters to a Vote of Security Holders.

On May 24, 2010, UnitedHealth Group Incorporated (the “Company”) held its annual meeting of shareholders. There were 967,209,320 shares of common stock represented either in person or by proxy at this meeting. The shareholders of the Company voted as follows on the following matters at the annual meeting:

 

1.

Election of Directors. The nine directors were elected at the annual meeting for a one-year term based upon the following votes:

 

Director Nominee		For		Against		Abstain		Broker Non-Votes
William C. Ballard, Jr.		792,982,641		104,671,425		832,533		68,722,721
Richard T. Burke		809,387,499		88,410,285		688,815		68,722,721
Robert J. Darretta		881,220,552		16,437,968		828,079		68,722,721
Stephen J. Hemsley		825,100,058		72,657,198		729,343		68,722,721
Michele J. Hooper		872,981,978		24,608,641		895,980		68,722,721
Douglas W. Leatherdale		806,147,133		91,596,610		742,856		68,722,721
Glenn M. Renwick		877,333,499		20,230,937		922,163		68,722,721
Kenneth I. Shine, M.D.		887,534,122		10,083,682		868,795		68,722,721
Gail R. Wilensky, Ph.D.		723,877,627		173,895,036		713,936		68,722,721

 

2.

Ratification of the appointment of Deloitte & Touche LLP. The appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2010 was ratified based upon the following votes:

 

For		Against		Abstain
863,396,594		103,215,197		597,529

 

3.

Shareholder proposal regarding lobbying expenses. The shareholder proposal concerning disclosure of lobbying expenditures was not approved based upon the following votes:

 

For		Against		Abstain		Broker Non-Votes
65,839,025		637,954,695		194,688,711		68,726,889

 

4.

Shareholder proposal regarding executive compensation. The shareholder proposal concerning an advisory vote on executive compensation was not approved based upon the following votes:

 

For		Against		Abstain		Broker Non-Votes
413,114,356		427,379,635		57,987,701		68,727,628

 

2

---

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: May 28, 2010

 

 

3